The activity of protein arginine deiminase 4 (PAD4) is comprehensively involved in the pathophysiology of rheumatoid arthritis (RA) partly through the production of immunogenic neoepitopes (1). This evidence concerns the gene PADI4 and rheumatoid arthritis.